Author

Miguel Areia

Q&A Gastric polyps and submucosal lesions: Less is more - Gastric Polyps
Q&A Gastric polyps and submucosal lesions: Less is more - Gastric Polyps

Miguel Areia  et al.

A clinical case demonstrating gastric fundic glands/hyperplastic polyps with dysplasia
A clinical case demonstrating gastric fundic glands/hyperplastic polyps with dysplasia

Miguel Areia

Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative
Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative

Miguel Areia  et al.

DELAYED BLEEDING AFTER ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL LESIONS >20MM: EXTERNAL VALIDATION AND UTILITY OF THE GSEED-RE2 CLINICAL SCORE
DELAYED BLEEDING AFTER ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL LESIONS >20MM: EXTERNAL VALIDATION AND UTILITY OF THE GSEED-RE2 CLINICAL SCORE

Miguel Areia  et al.

SURVEILLANCE OF COLORECTAL ENDOSCOPIC MUCOSAL RESECTIONS (EMR): A SINGLE CENTRE TEN-YEAR EXPERIENCE
SURVEILLANCE OF COLORECTAL ENDOSCOPIC MUCOSAL RESECTIONS (EMR): A SINGLE CENTRE TEN-YEAR EXPERIENCE

Miguel Areia  et al.

IS THERE PLACE TO EXCLUSIVE ENDOSCOPIC RESECTION FOR HIGH RISK MALIGNANT COLORECTAL POLYPS?
IS THERE PLACE TO EXCLUSIVE ENDOSCOPIC RESECTION FOR HIGH RISK MALIGNANT COLORECTAL POLYPS?

Miguel Areia  et al.

AN ASTOUNDING PERCUTANEOUS ENDOSCOPIC GASTROSTOMY COMPLICATION: PSEUDOANEURYSM OF GASTRODUODENAL ARTERY
AN ASTOUNDING PERCUTANEOUS ENDOSCOPIC GASTROSTOMY COMPLICATION: PSEUDOANEURYSM OF GASTRODUODENAL ARTERY

Miguel Areia  et al.

WILL RANDOM 100 PROCEDURES BE ENOUGH TO ESTIMATE UPPER GASTROINTESTINAL ENDOSCOPY QUALITY METRICS?
WILL RANDOM 100 PROCEDURES BE ENOUGH TO ESTIMATE UPPER GASTROINTESTINAL ENDOSCOPY QUALITY METRICS?

Miguel Areia  et al.

EFFECTIVENESS OF THE RECOMMENDED THERAPEUTIC PROTOCOLS IN HELICOBACTER PYLORI ERADICATION: A SINGLE CENTRE TEN-YEAR EXPERIENCE
EFFECTIVENESS OF THE RECOMMENDED THERAPEUTIC PROTOCOLS IN HELICOBACTER PYLORI ERADICATION: A SINGLE CENTRE TEN-YEAR EXPERIENCE

Miguel Areia  et al.

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portu
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portu

Miguel Areia  et al.

CAN ROUTINE BIOPSY OF COLORECTAL ENDOSCOPIC MUCOSAL RESECTION SCARS BE ABANDONED? - A MULTICENTRE RANDOMIZED SINGLE-BLINDED CROSSOVERTRIAL
CAN ROUTINE BIOPSY OF COLORECTAL ENDOSCOPIC MUCOSAL RESECTION SCARS BE ABANDONED? - A MULTICENTRE RANDOMIZED SINGLE-BLINDED CROSSOVERTRIAL

Miguel Areia  et al.

REAL-WORLD COMPARATIVE EFFECTS OF THREE-IN-ONE SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY VS. NON-BISMUTH QUADRUPLE CONCOMITANT THERAPY: INTERIM ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
REAL-WORLD COMPARATIVE EFFECTS OF THREE-IN-ONE SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY VS. NON-BISMUTH QUADRUPLE CONCOMITANT THERAPY: INTERIM ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Miguel Areia  et al.

EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 1,782 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 1,782 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

Miguel Areia  et al.

EFFECTIVENESS OF FIRST-LINE H. PYLORI ERADICATION THERAPY ACCORDING TO THE DAILY STATIN-USE: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF FIRST-LINE H. PYLORI ERADICATION THERAPY ACCORDING TO THE DAILY STATIN-USE: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Miguel Areia  et al.

EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE
EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE

Miguel Areia  et al.

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Miguel Areia  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Miguel Areia  et al.

THE COLON ENDOSCOPIC BUBBLE SCALE (CEBUS): A RELIABILITY STUDY
THE COLON ENDOSCOPIC BUBBLE SCALE (CEBUS): A RELIABILITY STUDY

Miguel Areia  et al.

COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Miguel Areia  et al.

DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Miguel Areia  et al.

Item 1 - 20 / 26
1
2